GT Biopharma (GTBP)

• Market cap: $13.4M
• 1 day: -3.67%
• 5 days: 6.89%
• 1 month: -7.29%
• 3 months: -22.13%
• 6 months: -42.96%
• Year to date: -54.08%
• 1 year: -83.97%
• 5 years: -99.92%
• 10 years: -99.76%
• Sector: Healthcare
• Industry: Biotechnology

About: GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.

Employees: 1